|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
|Tested Species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 1 and 273 of Human TEM8|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 20% glycerol|
|Storage conditions||-20° C, Avoid Freeze/Thaw Cycles|
PA5-30850 targets TEM8 in IHC (P) and WB applications and shows reactivity with Human samples.
The PA5-30850 immunogen is recombinant fragment corresponding to a region within amino acids 1 and 273 of Human TEM8.
This gene encodes a type I transmembrane protein and is a tumor-specific endothelial marker that has been implicated in colorectal cancer. The encoded protein has been shown to also be a docking protein or receptor for Bacillus anthracis toxin, the causative agent of the disease, anthrax. The binding of the protective antigen (PA) component, of the tripartite anthrax toxin, to this receptor protein mediates delivery of toxin components to the cytosol of cells. Once inside the cell, the other two components of anthrax toxin, edema factor (EF) and lethal factor (LF) disrupt normal cellular processes. Three alternatively spliced variants that encode different protein isoforms have been described.
Protein Aliases: 2310008J16Rik; 2810405N18Rik; Anthrax toxin receptor 1; ATR; TEM8; Tumor endothelial marker 8
Gene Aliases: ANTXR1; ATR; GAPO; TEM8
UniProt ID: (Human) Q9H6X2
Entrez Gene ID: (Human) 84168
Molecular Function: receptor